ProfileGDS4459 / ENSG00000103363
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 75% 74% 79% 85% 77% 78% 79% 76% 76% 76% 72% 75% 75% 80% 76% 78% 73% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 15.5575
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 25.4574
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 36.1479
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 46.3785
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 55.8477
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 65.8478
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 76.0679
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 85.8676
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 95.8576
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 105.8476
GSM623474group B, liver allograft wedge biopsie placebo treatment 15.3772
GSM623475group B, liver allograft wedge biopsie placebo treatment 25.7875
GSM623476group B, liver allograft wedge biopsie placebo treatment 35.6575
GSM623477group B, liver allograft wedge biopsie placebo treatment 45.8480
GSM623478group B, liver allograft wedge biopsie placebo treatment 55.9276
GSM623479group B, liver allograft wedge biopsie placebo treatment 65.7278
GSM623480group B, liver allograft wedge biopsie placebo treatment 75.3973